OLIVIA ALPERT: Open Payments
NPI 1447733894 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,291 in 107 payments from 18 companies in 2025. Trend: 2023 $64 · 2024 $1,050 · 2025 $2,291
Food & beverage: $2,139Education: $152
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $361 |
| Janssen Biotech, Inc. | 12 | $284 |
| Galderma Laboratories, L.P. | 8 | $233 |
| UCB, Inc. | 7 | $202 |
| Lilly USA, LLC | 9 | $178 |
| Incyte Corporation | 12 | $176 |
| Amgen Inc. | 6 | $168 |
| E.R. Squibb & Sons, L.L.C. | 6 | $145 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| LEO Pharma Inc. | 3 | $76 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, Bimzelx, OPZELURA, OTEZLA, DUPIXENT, Sotyktu.
Industry payments across MA — which companies pay providers there.
